Evaluation of Progesterone Agent Utilization and Birth Outcomes in a State Medicaid Plan

Friday, February 24, 2017
Image of poster
Tasmina Hydery, PharmD, MBA, CGP
University of Massachusetts Medical School
Mylissa Price, MPH, BS, RPh
University of Massachusetts Medical School
Bonnie Greenwood, PharmD, BCPS
University of Massachusetts Medical School
Mito Takeshita, PharmD
University of Massachusetts Medical School
Rose Mauro, MPH, CPh
University of Massachusetts Medical School
Parag Kunte, MPH
University of Massachusetts Medical School
Kimberly Lenz, PharmD
University of Massachusetts Medical School
Paul L. Jeffrey, PharmD
University of Massachusetts Medical School

An analysis of medication adherence and birth outcomes among members receiving progesterone for the prevention of preterm birth in a state Medicaid program. Data is also used to evaluate the association between member characteristics and medication adherence and birth outcomes as well as whether there was a change in the cost of care.

Conference 
American Drug Utilization Review Society 2017